News for United Therapeutics Corp.

TipRanks 7d

Wells Fargo Sticks to Their Hold Rating for United Therapeutics (UTHR)

TipRanks 8d

United Therapeutics (UTHR) Gets a Hold from Bank of America Securities

TipRanks 8d

United Therapeutics price target lowered to $315 from $321 at BofA

Seeking Alpha 8d

Biggest stock movers Tuesday: LMNR, NVO, INSM, and more

TipRanks 9d

Morning Movers: Insmed jumps, United Therapeutics falls after TPIP study results

TipRanks 9d

United Therapeutics falls after Insmed’s TPIP meets endpoints in study

Seeking Alpha 9d

Liquidia, United Therapeutics fall after mid-stage data for Insmed’s PAH asset

TipRanks 17d

Liquidia price target raised to $32 from $25 at Needham

TipRanks 17d

Liquidia schedules first commercial shipment of YUTREPIA

TipRanks 17d

United Therapeutics initiated with an Overweight at Cantor Fitzgerald

TipRanks 22d

Liquidia price target raised to $23 from $20 at Wells Fargo

TipRanks 22d

Analysts’ Top Healthcare Picks: United Therapeutics (UTHR), Replimune Group (REPL)

TipRanks 22d

Liquidia price target raised to $37 from $29 at BTIG

TipRanks 22d

Liquidia price target raised to $31 from $27 at Jefferies

TipRanks 23d

Liquidia price target raised to $25 from $22 at BofA

Seeking Alpha 26d

Liquidia's Yutrepia gets FDA approval for added indication

TipRanks 26d

Liquidia announces FDA approval of Yutrepia

Seeking Alpha 28d

The most crowded stocks by hedge funds based on their 13F filings

TipRanks 43d

Analysts Offer Insights on Healthcare Companies: United Therapeutics (UTHR), Pennant Group (PNTG) and Roche Holding AG (OtherRHHVF)

TipRanks 44d

United Therapeutics price target lowered to $345 from $375 at Argus

TipRanks 45d

Analysts Offer Insights on Healthcare Companies: United Therapeutics (UTHR), Oric Pharmaceuticals (ORIC) and CVS Health (CVS)

TipRanks 47d

Court dismisses United Therapeutics’ dispute against Liquidia

TipRanks 47d

Liquidia rallies after judge rules against bid to delay Yutrepia

TipRanks 47d

Liquidia price target raised at Scotiabank after ‘best case’ court ruling

Seeking Alpha 47d

Liquidia surges 15% as court clears way for Yutrepia launch (updated)

TipRanks 49d

United Therapeutics (UTHR) Gets a Hold from Wells Fargo

TipRanks 50d

United Therapeutics reports Q1 EPS $6.63, consensus $6.28

Seeking Alpha 50d

United Therapeutics GAAP EPS of $6.63 beats by $0.35, revenue of $794.4M beats by $68.04M

Seeking Alpha 50d

United Therapeutics Q1 2025 Earnings Preview

TipRanks 55d

Wells Fargo downgrades United Therapeutics on IPF data concerns

TipRanks 55d

Analysts Offer Insights on Healthcare Companies: Sanofi (OtherSNYNF), Biogen (BIIB) and United Therapeutics (UTHR)

TipRanks 55d

United Therapeutics (UTHR) was downgraded to a Hold Rating at Wells Fargo

TipRanks 55d

United Therapeutics downgraded to Equal Weight from Overweight at Wells Fargo

TipRanks 59d

United Therapeutics upgraded to Neutral at BofA following selloff

TipRanks 59d

United Therapeutics upgraded to Neutral from Underperform at BofA

TipRanks 73d

Analysts Offer Insights on Healthcare Companies: United Therapeutics (UTHR), Roche Holding AG (OtherRHHVF) and AstraZeneca (AZN)

TipRanks 76d

United Therapeutics to present 10 posters, presentations at USHLT

Seeking Alpha 82d

Liquidia says its request for Yutrepia final approval undergoes FDA review

TipRanks 92d

United Therapeutics price target lowered to $314 from $328 at BofA

TipRanks 94d

Analysts Have Conflicting Sentiments on These Healthcare Companies: Molecular Partners (MOLN), United Therapeutics (UTHR) and Universal Health (UHS)

TipRanks 110d

Analysts Offer Insights on Healthcare Companies: United Therapeutics (UTHR) and Beam Therapeutics (BEAM)

TipRanks 111d

United Therapeutics price target lowered to $420 from $430 at Leerink

TipRanks 111d

United Therapeutics price target lowered to $346 from $354 at Morgan Stanley

TipRanks 112d

Analysts Are Bullish on Top Healthcare Stocks: United Therapeutics (UTHR), Geron (GERN)

TipRanks 112d

United Therapeutics (UTHR) Gets a Buy from Wells Fargo

TipRanks 112d

Morning Movers: TJX and Lowe’s gain following fourth quarter results

TipRanks 113d

United Therapeutics reports Q4 EPS $6.19, consensus $6.27

Seeking Alpha 113d

United Therapeutics GAAP EPS of $6.19 misses by $0.08, revenue of $735.9M beats by $1.16M

Seeking Alpha 113d

Here's the major earnings before the open tomorrow

Seeking Alpha 113d

United Therapeutics Q4 2024 Earnings Preview

	
		OSZAR »